Form 4: Amgen SVP & CCO Nancy Grygiel Reports Stock Sale and RSU Vesting

Nancy Grygiel, SVP & CCO of Amgen, reported the sale of 2,117 shares of common stock and the vesting of Restricted Stock Units (RSUs) on May 3, 2024.

Summary

• On May 3, 2024, Nancy A. Grygiel, SVP & CCO of Amgen Inc., filed a Form 4 indicating changes in beneficial ownership.
• Grygiel sold 2,117 shares of Amgen common stock at an average price of $313.0853 per share.
• The sale resulted in Grygiel directly owning 9,883 shares following the transaction.
• Grygiel also indirectly owns 99.9653 shares through the company's 401(k) plan.
• The reported holdings include Restricted Stock Units (RSUs) vesting at various dates in the future.
• These RSUs will be paid in shares of Amgen's common stock on a one-to-one basis.
• The holdings also include Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Tracking insider transactions is a common practice in financial analysis.
• Comparing the volume and frequency of insider sales at Amgen to those of its peers in the biotechnology industry (e.g., Gilead Sciences, Biogen) can provide context.
• For example, if other executives in comparable companies are also selling shares, it might indicate broader industry trends or personal financial planning rather than company-specific concerns.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, although it is a common practice.
• The vesting of RSUs and subsequent sale of shares is a typical form of executive compensation.

Key Dates